Value-based care and interoperability continue to progress in the United States, but barriers that limit sharing of clinical information among hospitals, physicians, and health plans remain, according to a study by the Healthcare Financial Management Association (HFMA) and sponsored by Humana.
Value-based care and interoperability continue to progress in the United States, but barriers that limit sharing of clinical information among hospitals, physicians, and health plans remain, according to a study by the Healthcare Financial Management Association (HFMA) and sponsored by Humana.
Three main barriers that slow the progression of value-based care include:
Interoperability between hospitals, physicians, and patients was recognized as extremely important by the respondents. In 2017, half of respondents found interoperability improvement across health networks and recognized health plans as extremely important.
“Interoperability has the challenge of collecting fragmented health data and exchanging the information across multiple systems. In addition, it must provide physicians access to comprehensible patient health information at the right time for informed decision making and better efficiencies. Overcoming the interoperability barrier becomes even more important for treating patients with chronic conditions as they generally see multiple physicians and specialists,” Roy Beveridge, MD, Humana’s chief medical officer, said in a press release.
The main findings from the 2017 study include a 2-fold increase in health plans’ use of value based mechanisms since 2015, as well as penetration of value-based payment in negotiated governmental plans coming in at 26%. The survey also found that 74% of respondents reported their organizations achieved positive financial results from value-based payment programs and 75% of respondents stated regulatory uncertainty, including the Medicare Access and CHIP Reauthorization Act, has a negative effect on their ability to forecast the financial impact of value-based payment.
It was also recognized that more resources and funding must support patients in need of chronic care and patients affected by social determinants. Almost two-thirds (65%) of respondents found that their organizations do not have the tools to assist in specialty or inpatient care to help control costs and 63% of respondents found that their organizations do not consider social determinants of health in planning overall strategy and cost planning.
“Collaboration among health systems, physicians, and health plans is the key to growing value-based payment,” said HFMA President and CEO Joseph J. Fifer, FHFMA, CPA. “Technology and other obstacles can be overcome if all stakeholders commit to working together for the benefit of the people we serve.”
AstraZeneca joins efforts to address high drug prices by capping out-of-pocket costs for its inhalers; Opill, the first OTC birth control pill, is now accessible through online sales; expansion prompts questions on the effectiveness and regulation of remote monitoring technology.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Federated Learning Models Show Potential in Melanoma-Nevus Classification, but Improvements Needed
March 16th 2024A multicentric, single-arm diagnostic study created a decentralized federated learning model for the classification of invasive melanomas and nevi, showcasing comparable results to centralized data models.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen